Damato B. Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view. Prog Retin Eye Res. 2018;66:187–99. https://doi.org/10.1016/j.preteyeres.2018.03.004.

Article  PubMed  Google Scholar 

Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye. 2017;31(2):241–57. https://doi.org/10.1038/eye.2016.275.

Article  PubMed  CAS  Google Scholar 

Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivela T. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology. 2003;110(11):2223–34. https://doi.org/10.1016/S0161-6420(03)00661-4.

Article  PubMed  Google Scholar 

Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, et al. Plaque radiotherapy for large posterior uveal melanomas (> or = 8-mm thick) in 354 consecutive patients. Ophthalmology. 2002;109(10):1838–49. https://doi.org/10.1016/s0161-6420(02)01181-8.

Article  PubMed  Google Scholar 

Bechrakis NE, Bornfeld N, Zoller I, Foerster MH. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas. Ophthalmology. 2002;109(10):1855–61.

Article  PubMed  Google Scholar 

Guberina M, Sokolenko E, Guberina N, Dalbah S, Pottgen C, Lubcke W, et al. Feasibility, method and early outcome of image-guided Volumetric Modulated Arc Radiosurgery followed by Resection for AJCC Stage IIA-IIIB High-Risk large intraocular melanoma. Cancers (Basel). 2022;14(19). https://doi.org/10.3390/cancers14194729.

Fallico M, Chronopoulos A, Schutz JS, Reibaldi M. Treatment of radiation maculopathy and radiation-induced macular edema: a systematic review. Surv Ophthalmol. 2021;66(3):441–60. https://doi.org/10.1016/j.survophthal.2020.08.007.

Article  PubMed  Google Scholar 

Oare C, Sun S, Dusenbery K, Reynolds M, Koozekanani D, Gerbi B, et al. Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities - a retrospective study using COMS eye plaques. Phys Med. 2022;101:71–8. https://doi.org/10.1016/j.ejmp.2022.08.001.

Article  PubMed  Google Scholar 

Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, et al. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report 16. Ophthalmology. 2001;108(2):348–66. https://doi.org/10.1016/s0161-6420(00)00526-1.

Article  PubMed  CAS  Google Scholar 

Kheir WJ, Stinnett SS, Meltsner S, Semenova E, Mowery YM, Craciunescu O, et al. Preliminary results of uveal melanoma treated with Iodine-125 plaques: analysis of Disease Control and visual outcomes with 63 gy to the Target volume. Adv Radiat Oncol. 2022;7(2):100869. https://doi.org/10.1016/j.adro.2021.100869.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Saconn PA, Gee CJ, Greven CM, McCoy TP, Ekstrand KE, Greven KM. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Int J Radiat Oncol Biol Phys. 2010;78(3):844–8. https://doi.org/10.1016/j.ijrobp.2009.08.059.

Article  PubMed  CAS  Google Scholar 

O’Day RFJ, Roelofs KA, Negretti GS, Hay G, Arora AK, Stoker I, et al. Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma. Eye. 2023;37(5):959–65. https://doi.org/10.1038/s41433-022-01944-4.

Article  PubMed  CAS  Google Scholar 

Damato B, Patel I, Campbell IR, Mayles HM, Errington RD. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas. Int J Radiat Oncol Biol Phys. 2005;63(2):392–400. https://doi.org/10.1016/j.ijrobp.2005.02.059.

Article  PubMed  Google Scholar 

Aziz HA, Singh N, Bena J, Wilkinson A, Singh AD. Vision loss following Episcleral Brachytherapy for Uveal Melanoma: development of a Vision Prognostication Tool. JAMA Ophthalmol. 2016;134(6):615–20. https://doi.org/10.1001/jamaophthalmol.2016.0104.

Article  PubMed  Google Scholar 

Jabbarli L, Guberina M, Biewald E, Fluhs D, Guberina N, Le Guin CHD, et al. Scleral necrosis after brachytherapy for uveal melanoma: analysis of risk factors. Clin Exp Ophthalmol. 2021. https://doi.org/10.1111/ceo.13928.

Article  PubMed  Google Scholar 

Fluhs D, Anastassiou G, Wening J, Sauerwein W, Bornfeld N. The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators. Med Phys. 2004;31(6):1481–8. https://doi.org/10.1118/1.1755471.

Article  PubMed  CAS  Google Scholar 

Sauerwein W, Stannard CE. Auge Und Orbita. In: Bamberg M, Molls M, Sack H, Zuckschwerdt, editors. Radioonkologie Band 2: Klinik. München Wien New York: W.; 2009.

Google Scholar 

Version:2019 I-. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version 2019. https://icd.who.int/browse10/2019/en#/H54 (2019). Accessed.

Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, et al. Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients. Br J Ophthalmol. 2020;104(5):697–702. https://doi.org/10.1136/bjophthalmol-2019-314686.

Article  PubMed  Google Scholar 

Wisely CE, Hadziahmetovic M, Reem RE, Hade EM, Nag S, Davidorf FH, et al. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy. Brachytherapy. 2016;15(1):12–22. https://doi.org/10.1016/j.brachy.2015.09.013.

Article  PubMed  PubMed Central  Google Scholar 

Asplund E, Fili M, Pansell T, Brautaset R, Nilsson M, Stalhammar G. The prognostic implication of visual acuity at the time of uveal melanoma diagnosis. Eye. 2023;37(11):2204–11. https://doi.org/10.1038/s41433-022-02316-8.

Article  PubMed  Google Scholar 

Kal Omar R, Hagstrom A, Dahlander S, Carlsson Tedgren A, Stalhammar G. A prognostic score for the prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma. Adv Radiat Oncol. 2023;8(3):101152. https://doi.org/10.1016/j.adro.2022.101152.

Article  PubMed  CAS  Google Scholar 

King BA, Awh C, Gao BT, Wang J, Kocak M, Morales-Tirado VM, et al. Iodine-125 Episcleral Plaque Brachytherapy for AJCC T4 posterior uveal melanoma: clinical outcomes in 158 patients. Ocular Oncol Pathol. 2019;5(5):340–9. https://doi.org/10.1159/000495249.

Article  Google Scholar 

Shields CL, Shields JA, Cater J, Gunduz K, Miyamoto C, Micaily B, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000;118(9):1219–28. https://doi.org/10.1001/archopht.118.9.1219.

Article  PubMed  CAS  Google Scholar 

Yang X, Dalvin LA, Mazloumi M, Chang M, Shields JA, Mashayekhi A, et al. Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients. Clin Exp Ophthalmol. 2020;48(5):610–23. https://doi.org/10.1111/ceo.13758.

Article  PubMed  CAS  Google Scholar 

Pagliara MM, Tagliaferri L, Lenkowicz J, Azario L, Giattini D, Fionda B, et al. AVATAR: analysis for visual acuity prediction after Eye Interventional Radiotherapy. Vivo. 2020;34(1):381–7. https://doi.org/10.21873/invivo.11784.

Article  CAS  Google Scholar 

Victor AA, Andayani G, Djatikusumo A, Yudantha AR, Hutapea MM, Gunardi TH, et al. Efficacy of prophylactic Anti-VEGF in preventing Radiation Retinopathy: a systematic review and Meta-analysis. Clin Ophthalmol. 2023;17:2997–3009. https://doi.org/10.2147/OPTH.S433531.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Miguel D, de Frutos-Baraja JM, Lopez-Lara F, Saornil MA, Garcia-Alvarez C, Alonso P, et al. Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II. J Contemp Brachytherapy. 2018;10(4):347–59. https://doi.org/10.5114/jcb.2018.77955.

Article  PubMed  PubMed Central  Google Scholar 

Lalos F, Fluhs D, Guberina M, Bornfeld N, Stuschke M, Sauerwein W, et al. Treatment-related complications and functional results after Ruthenium-106 brachytherapy in small to medium size Uveal Melanomas (Part 2). Klin Monatsbl Augenheilkd. 2024. https://doi.org/10.1055/a-2275-5575.

Article  PubMed  Google Scholar 

Lalos F, Fluhs D, Guberina M, Bornfeld N, Stuschke M, Sauerwein W, et al. Tumor- and Radiation-related complications after Ruthenium-106 brachytherapy in small to medium uveal melanomas (part 1). Klin Monatsbl Augenheilkd. 2024. https://doi.org/10.1055/a-2268-0985.

Article  PubMed  Google Scholar 

Finger PT, Chin KJ, Yu GP. Palladium-103 for Choroidal Melanoma Study G. Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma. Am J Ophthalmol. 2010;149(4):608–15. https://doi.org/10.1016/j.ajo.2009.11.006.